Aims: Oral anticoagulation (OAC) therapy as secondary stroke prophylaxis in atrial fibrillation (AF) patients with chronic kidney disease (CKD) remains unexplored and poses a clinical treatment dilemma. We assessed the long-term risk of thromboembolic events according to post-stroke OAC therapy in AF patients with CKD after their first ischaemic stroke.
Methods And Results: We identified Danish AF patients with CKD who presented with first-time ischaemic stroke from 2005 to 2014.
Aims: Thromboprophylaxis guidelines for patients with concurrent atrial fibrillation (AF) during infections are unclear and not supported by data. We compared 1-year outcomes in patients with infection-related AF and infection without AF.
Methods And Results: By crosslinking Danish nationwide registry data, AF naïve patients admitted with infection (1996-2016) were identified.